Decoding type I and III interferon signalling during viral infection

Interferon (IFN)-mediated antiviral responses are central to host defence against viral infection. Despite the existence of at least 20 IFNs, there are only three known cell surface receptors. IFN signalling and viral evasion mechanisms form an immensely complex network that differs across species. In this Review, we begin by highlighting some of the advances that have been made towards understanding the complexity of differential IFN signalling inputs and outputs that contribute to antiviral defences. Next, we explore some of the ways viruses can interfere with, or circumvent, these defences. Lastly, we address the largely under-reviewed impact of IFN signalling on host tropism, and we offer perspectives on the future of research into IFN signalling complexity and viral evasion across species.This Review highlights some of the advances that have been made towards understanding the complexity of differential interferon (IFN) signalling inputs and outputs as well as some of the strategies viruses use to interfere with or circumvent IFN-induced antiviral responses.

[1]  Tsung-Han Hsieh,et al.  Proteomic analysis for Type I interferon antagonism of Japanese encephalitis virus NS5 protein , 2013, Proteomics.

[2]  H. Ebihara,et al.  Antagonism of Type I Interferon Responses by New World Hantaviruses , 2010, Journal of Virology.

[3]  P. Zhou,et al.  Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats , 2016, Proceedings of the National Academy of Sciences.

[4]  A. Cheng,et al.  Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins , 2017, Viruses.

[5]  K. Garcia,et al.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation , 2012, Immunological reviews.

[6]  Haitao Guo,et al.  Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections , 2010, Journal of Virology.

[7]  E. Zúñiga,et al.  Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. , 2005, Immunity.

[8]  C. Rice,et al.  IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage , 2013, The EMBO journal.

[9]  S. Best The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling , 2016, Journal of Virology.

[10]  R. Means,et al.  Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response , 2014, Nature.

[11]  P. Hulpiau,et al.  Mx Proteins: Antiviral Gatekeepers That Restrain the Uninvited , 2013, Microbiology and Molecular Reviews.

[12]  Evita T. Sadimin,et al.  Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo , 2017, mBio.

[13]  Hiroki Sato,et al.  Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation , 2017, Journal of Virology.

[14]  Mamta Chawla-Sarkar,et al.  Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  T. Pisitkun,et al.  Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells* , 2018, Molecular & Cellular Proteomics.

[16]  G. Hartmann,et al.  Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates , 2014, Nature.

[17]  A. Lewis-Antes,et al.  IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex , 2003, Nature Immunology.

[18]  S. Kotenko,et al.  Interferon‐&lgr; Mediates Non‐redundant Front‐Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness , 2017, Immunity.

[19]  L. Prokunina-Olsson,et al.  IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling , 2017, The Journal of Immunology.

[20]  Michael Gale,et al.  Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA , 2008, Nature.

[21]  M. Jantsch,et al.  Rapid and dynamic transcriptome regulation by RNA editing and RNA modifications , 2016, The Journal of cell biology.

[22]  M. Shiffman,et al.  Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection , 2010, Hepatology.

[23]  G. Stark,et al.  Complex modulation of cell type-specific signaling in response to type I interferons. , 2006, Immunity.

[24]  G. Moseley,et al.  Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease. , 2014, The Journal of infectious diseases.

[25]  W. Windsor,et al.  Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor , 1995, Nature.

[26]  A. García-Sastre,et al.  The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. , 2014, Cell host & microbe.

[27]  C. Rice,et al.  Interferon-stimulated genes and their antiviral effector functions , 2011, Current Opinion in Virology.

[28]  Zhijian J. Chen,et al.  DNA-induced liquid phase condensation of cGAS activates innate immune signaling , 2018, Science.

[29]  Thao Nguyen,et al.  The interferons and their receptors—distribution and regulation , 2012, Immunology and cell biology.

[30]  Roger Williams,et al.  Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients , 2017, Front. Immunol..

[31]  B. Pulendran,et al.  Zika Virus Antagonizes Type I Interferon Responses during Infection of Human Dendritic Cells , 2017, PLoS pathogens.

[32]  Arun K. Ghosh,et al.  Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases , 2010, Journal of Virology.

[33]  C. V. van Eijck,et al.  Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells , 2014, Journal of cellular and molecular medicine.

[34]  T. Giese,et al.  RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus replication. , 2011, The Journal of general virology.

[35]  C. D. Krause,et al.  Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.

[36]  G. Schreiber The molecular basis for differential type I interferon signaling , 2017, The Journal of Biological Chemistry.

[37]  Mamta Chawla-Sarkar,et al.  Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN-β Compared with IFN-α2 , 2003 .

[38]  T. Kepler,et al.  The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity , 2018, Cell.

[39]  L. Prokunina-Olsson,et al.  IFN-λ4: the paradoxical new member of the interferon lambda family. , 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  S. Barik,et al.  Respiratory Syncytial Virus Nonstructural Proteins Decrease Levels of Multiple Members of the Cellular Interferon Pathways , 2009, Journal of Virology.

[41]  T. Wolff,et al.  Activation of the Antiviral Kinase PKR and Viral Countermeasures , 2009, Viruses.

[42]  C. Rice,et al.  Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients , 2018, The Journal of infectious diseases.

[43]  C. Rice,et al.  The IFN‐&lgr;‐IFN‐&lgr;R1‐IL‐10R&bgr; Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity , 2017, Immunity.

[44]  Barbara Rehermann,et al.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.

[45]  S. Kakinuma,et al.  Hepatitis C virus NS4B protein targets STING and abrogates RIG‐I–mediated type I interferon‐dependent innate immunity , 2013, Hepatology.

[46]  S. Schwartz,et al.  TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion , 2017, Aging.

[47]  C. Horvath,et al.  Hendra Virus V Protein Inhibits Interferon Signaling by Preventing STAT1 and STAT2 Nuclear Accumulation , 2003, Journal of Virology.

[48]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[49]  K. Takeuchi,et al.  The STAT2 Activation Process Is a Crucial Target of Sendai Virus C Protein for the Blockade of Alpha Interferon Signaling , 2003, Journal of Virology.

[50]  J. Torchia,et al.  Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. , 2012, Cell host & microbe.

[51]  N. Kato,et al.  Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. , 2013, Journal of hepatology.

[52]  A. García-Sastre,et al.  Dengue Virus Co-opts UBR4 to Degrade STAT2 and Antagonize Type I Interferon Signaling , 2013, PLoS pathogens.

[53]  Diego Jaitin,et al.  The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities* , 2008, Journal of Biological Chemistry.

[54]  Q. Ding,et al.  Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease , 2018, Proceedings of the National Academy of Sciences.

[55]  D. Lenschow,et al.  The Antiviral Activities of ISG15 , 2013, Journal of Molecular Biology.

[56]  N. Reich,et al.  The Pathogenic NY-1 Hantavirus G1 Cytoplasmic Tail Inhibits RIG-I- and TBK-1-Directed Interferon Responses , 2006, Journal of Virology.

[57]  S. Beinke,et al.  IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment , 2016, EMBO molecular medicine.

[58]  C. Schindler,et al.  Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2* , 2011, The Journal of Biological Chemistry.

[59]  B. Williams,et al.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.

[60]  Jianguo Wu,et al.  HERP Binds TBK1 To Activate Innate Immunity and Repress Virus Replication in Response to Endoplasmic Reticulum Stress , 2017, The Journal of Immunology.

[61]  Anthony A. Hyman,et al.  Biomolecular condensates: organizers of cellular biochemistry , 2017, Nature Reviews Molecular Cell Biology.

[62]  Jianfei Chen,et al.  The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. , 2013, The Journal of general virology.

[63]  Pei-Yong Shi,et al.  NS5 of Dengue Virus Mediates STAT2 Binding and Degradation , 2009, Journal of Virology.

[64]  R. Lamb,et al.  The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. , 2001, Virology.

[65]  C. Horvath,et al.  STAT2 Is a Primary Target for Measles Virus V Protein-Mediated Alpha/Beta Interferon Signaling Inhibition , 2008, Journal of Virology.

[66]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[67]  S. Aguirre,et al.  DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING , 2012, PLoS pathogens.

[68]  Lin‐Fa Wang,et al.  Bats and their virome: an important source of emerging viruses capable of infecting humans , 2012, Current Opinion in Virology.

[69]  K. Błaszczyk,et al.  A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses , 2018, Front. Immunol..

[70]  T. Wolff,et al.  Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Bernd Fischer,et al.  Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate Immune Responses , 2016, Cell Host & Microbe.

[72]  T. Briese,et al.  Z Proteins of New World Arenaviruses Bind RIG-I and Interfere with Type I Interferon Induction , 2009, Journal of Virology.

[73]  M. Heim,et al.  SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo , 2017, The Journal of Biological Chemistry.

[74]  G. Schröder,et al.  Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. , 2011, Immunity.

[75]  H. Field,et al.  Bats: Important Reservoir Hosts of Emerging Viruses , 2006, Clinical Microbiology Reviews.

[76]  S. Kotenko,et al.  Interferon-lambda: a new addition to an old family. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[77]  anonymous,et al.  Comprehensive review , 2019 .

[78]  Maxim N. Artyomov,et al.  An Immunocompetent Mouse Model of Zika Virus Infection. , 2018, Cell host & microbe.

[79]  Diego Jaitin,et al.  Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β , 2006, Molecular and Cellular Biology.

[80]  W. Liu,et al.  Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform , 2014, Journal of molecular cell biology.

[81]  Yi-Ling Lin,et al.  Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate Immunity , 2012, PLoS pathogens.

[82]  P. Sehgal,et al.  Interferon-α-induced cytoplasmic MxA structures in hepatoma Huh7 and primary endothelial cells , 2018, Contemporary oncology.

[83]  Adolfo García-Sastre,et al.  Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. , 2016, Cell host & microbe.

[84]  T. Takimoto,et al.  Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. , 2006, Virus research.

[85]  Maulik R. Patel,et al.  Convergent Evolution of Escape from Hepaciviral Antagonism in Primates , 2012, PLoS biology.

[86]  M. Behlke,et al.  Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. , 2006, Virology.

[87]  T. Takimoto,et al.  Antagonism of Innate Immunity by Paramyxovirus Accessory Proteins , 2009, Viruses.

[88]  J. Tavernier,et al.  Dimerization of the Interferon Type I Receptor IFNaR2–2 Is Sufficient for Induction of Interferon Effector Genes but Not for Full Antiviral Activity* , 1999, The Journal of Biological Chemistry.

[89]  C. Spencer,et al.  Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C , 2018, Hepatology.

[90]  M. Hornef,et al.  IFN-λ determines the intestinal epithelial antiviral host defense , 2011, Proceedings of the National Academy of Sciences.

[91]  J. Teijaro Type I interferons in viral control and immune regulation , 2016, Current Opinion in Virology.

[92]  C. Power,et al.  Zika virus inhibits type‐I interferon production and downstream signaling , 2016, EMBO reports.

[93]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[94]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[95]  A. García-Sastre,et al.  Antagonism of type I interferon by flaviviruses. , 2017, Biochemical and biophysical research communications.

[96]  Ren-Jye Lin,et al.  Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism , 2006, Journal of Virology.

[97]  Kui Li,et al.  Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling , 2012, PloS one.

[98]  Albert C. Huang,et al.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier , 2015, Science Translational Medicine.

[99]  C. Cameron,et al.  The 3′ Untranslated Regions of Influenza Genomic Sequences Are 5′PPP-Independent Ligands for RIG-I , 2012, PloS one.

[100]  Yuqiong Liang,et al.  Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor , 2007, Proceedings of the National Academy of Sciences.

[101]  J. Rossjohn,et al.  Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection , 2013, Science.

[102]  Chao Xing,et al.  A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication , 2018, Nature Microbiology.

[103]  S. Pestka,et al.  Binding and activity of all human alpha interferon subtypes. , 2011, Cytokine.

[104]  S. Pellegrini,et al.  USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response , 2011, PloS one.

[105]  John Karijolich,et al.  RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection , 2018, Nature Communications.

[106]  A. García-Sastre Ten Strategies of Interferon Evasion by Viruses , 2017, Cell Host & Microbe.

[107]  T. Waldmann,et al.  Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma , 2018, Proceedings of the National Academy of Sciences.

[108]  Lihan K. Yan,et al.  Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells. , 2017, Virology.

[109]  W. Windsor,et al.  Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. , 1995, Nature.

[110]  M. Schwemmle,et al.  Genome trimming by Borna disease viruses: Viral replication control or escape from cellular surveillance? , 2007, Cellular and Molecular Life Sciences.

[111]  O. Sanal,et al.  ISG15 deficiency and increased viral resistance in humans but not mice , 2016, Nature Communications.

[112]  Xuetao Cao,et al.  Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review. , 2017, Journal of autoimmunity.

[113]  A. García-Sastre,et al.  Arterivirus and Nairovirus Ovarian Tumor Domain-Containing Deubiquitinases Target Activated RIG-I To Control Innate Immune Signaling , 2011, Journal of Virology.

[114]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[115]  Limin Chen,et al.  MxA is a positive regulator of type I IFN signaling in HCV infection , 2017, Journal of medical virology.

[116]  S. Goodbourn,et al.  Paramyxovirus V Proteins Interact with the RNA Helicase LGP2 To Inhibit RIG-I-Dependent Interferon Induction , 2012, Journal of Virology.

[117]  S. Riaz,et al.  Innate Sensing of Influenza A Virus Hemagglutinin Glycoproteins by the Host Endoplasmic Reticulum (ER) Stress Pathway Triggers a Potent Antiviral Response via ER-Associated Protein Degradation , 2017, Journal of Virology.

[118]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[119]  T. Wolff,et al.  Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1 , 2005 .

[120]  P. Zhou,et al.  Dampened STING-Dependent Interferon Activation in Bats , 2018, Cell Host & Microbe.

[121]  S. Pellegrini,et al.  Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling , 2015, The Journal of cell biology.

[122]  V. Volchkov,et al.  The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[123]  C. Horvath,et al.  Nipah Virus V Protein Evades Alpha and Gamma Interferons by Preventing STAT1 and STAT2 Activation and Nuclear Accumulation , 2002, Journal of Virology.

[124]  A. Barrett,et al.  The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling , 2010, Journal of Virology.

[125]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[126]  S. Aguirre,et al.  Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection , 2017, Nature Microbiology.

[127]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[128]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[129]  S. Whelan,et al.  STING-dependent translation inhibition restricts RNA virus replication , 2018, Proceedings of the National Academy of Sciences.

[130]  Zhongbin Chen,et al.  SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex , 2014, Protein & Cell.

[131]  D. Levy,et al.  IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff , 2002, Nature Cell Biology.

[132]  R. Hilgenfeld,et al.  RNA‐virus proteases counteracting host innate immunity , 2017, FEBS letters.

[133]  Scott R. Presnell,et al.  IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.

[134]  C. Horvath,et al.  Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection. , 2008, Virology.

[135]  D. Garcin,et al.  IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission , 2018, eLife.

[136]  L. Ivashkiv,et al.  Role of STAT3 in Type I Interferon Responses , 2006, Journal of Biological Chemistry.

[137]  Yuqiong Liang,et al.  Disruption of TLR3 Signaling Due to Cleavage of TRIF by the Hepatitis A Virus Protease-Polymerase Processing Intermediate, 3CD , 2011, PLoS pathogens.

[138]  B. Chain,et al.  Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. , 2009, The Journal of infectious diseases.

[139]  G. Schreiber,et al.  Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities , 2009, Molecular and Cellular Biology.

[140]  Christopher T. Jones,et al.  A diverse array of gene products are effectors of the type I interferon antiviral response , 2011, Nature.

[141]  L. Ivashkiv,et al.  Regulation of type I interferon responses , 2013, Nature Reviews Immunology.

[142]  Fatema Z. Chowdhury,et al.  STAT2: A shape-shifting anti-viral super STAT. , 2013, JAK-STAT.

[143]  Ren-Jye Lin,et al.  Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection , 2004, Journal of Virology.

[144]  M. Katze,et al.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. , 2015, Cell host & microbe.

[145]  K. Shuai,et al.  UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.

[146]  Jessica K. Fiege,et al.  Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo , 2018, Proceedings of the National Academy of Sciences.

[147]  R. Norton,et al.  Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. , 2012, Immunity.

[148]  C. Horvath,et al.  Identification of the Nuclear Export Signal and STAT-Binding Domains of the Nipah Virus V Protein Reveals Mechanisms Underlying Interferon Evasion , 2004, Journal of Virology.

[149]  Michiel van Gent,et al.  Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I mediated immunity , 2017, Nature Immunology.

[150]  C. Horvath,et al.  Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. , 2004, Viral immunology.

[151]  B. Damania,et al.  The cGAS-STING Defense Pathway and Its Counteraction by Viruses , 2016, Cell Host & Microbe.

[152]  K. Takeuchi,et al.  Sendai virus C protein physically associates with Stat1 , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[153]  C. Rice,et al.  Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection , 2002, Journal of Virology.

[154]  Zejun Li,et al.  A Single Mutation at Position 156 in the Envelope Protein of Tembusu Virus Is Responsible for Virus Tissue Tropism and Transmissibility in Ducks , 2018, Journal of Virology.

[155]  S. Kotenko,et al.  Type III interferon is a critical regulator of innate antifungal immunity , 2017, Science Immunology.

[156]  E. Mackow,et al.  An Innate Immunity-Regulating Virulence Determinant Is Uniquely Encoded within the Andes Virus Nucleocapsid Protein , 2014, mBio.

[157]  Diego Jaitin,et al.  Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. , 2006, Molecular and cellular biology.

[158]  M. Albert,et al.  Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia , 2013, PLoS pathogens.

[159]  D. Garcin,et al.  Short Double-stranded RNAs with an Overhanging 5′ ppp-Nucleotide, as Found in Arenavirus Genomes, Act as RIG-I Decoys* , 2010, The Journal of Biological Chemistry.

[160]  R. Bartenschlager,et al.  Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus , 2010, PloS one.

[161]  Jeffrey L. Brodsky,et al.  One step at a time: endoplasmic reticulum-associated degradation , 2008, Nature Reviews Molecular Cell Biology.

[162]  E. Kurt-Jones,et al.  Pattern Recognition Receptors and the Innate Immune Response to Viral Infection , 2011, Viruses.

[163]  Joshua B. Singer,et al.  Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses , 2017, PLoS biology.

[164]  C. Horvath,et al.  STAT2 Acts as a Host Range Determinant for Species-Specific Paramyxovirus Interferon Antagonism and Simian Virus 5 Replication , 2002, Journal of Virology.

[165]  S. Orkin,et al.  ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling , 2008, Nature Immunology.

[166]  T. Takimoto,et al.  Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. , 2009, The Journal of general virology.

[167]  G. Foster,et al.  Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression , 2005, Journal of Virology.

[168]  M. Dallman,et al.  Impaired Antiviral Response and Alpha/Beta Interferon Induction in Mice Lacking Beta Interferon , 2000, Journal of Virology.

[169]  K. Garcia,et al.  The IFN-lambda-IFN-lambda R1-IL-10R beta Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. , 2017 .

[170]  D. Levy,et al.  Tissue-specific Positive Feedback Requirements for Production of Type I Interferon following Virus Infection* , 2005, Journal of Biological Chemistry.

[171]  Peter O. Krutzik,et al.  Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons , 2011, Cell.

[172]  E. Ooi,et al.  Dengue virus activates cGAS through the release of mitochondrial DNA , 2017, Scientific Reports.